Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

Clinical trial NCT05285878 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT05285878
Sponsor: The Methodist Hospital Research Institute
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

Interstitial Fibrosis Kidney Transplant; Complications Kidney Transplant Rejection Kidney Transplant Failure and Rejection Kidney Transplant Failure Kidney Failure, Chronic Graft Rejection

Start date: 2022-07-28
Primary completion: 2027-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.